The Mometasone Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the future of the healthcare vertical.
Mometasone inhibits mast cells, lymphocytes, basophils and eosinophils in case of asthma to prevent asthma attacks. According to the American Academy of Dermatology (AAD), 1 in 10 people suffer from dermatitis during their lifetime, whereas 7.5 million suffer from psoriasis in the U.S.
Covid-19 has led to lockdown in several countries delaying manufacturing activities of mometasone market. There has been observed supply chain disruption due to restrictions laid on trading across borders by various countries impacting mometasone market.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32010
Reduced physician visits and treatment-seeking rates amid spread of coronavirus will slower mometasone market growth. Delay in research and development activities in the mometasone market is attributed to finding Covid-19 cure.
Growing patient population suffering from asthma increases the demand for mometasone market. Increasing collaborative research and development activities among leading biopharmaceutical players are expected to fuel mometasone market growth.
For instance, in February 2020, Hikma Pharmaceuticals and Glenmark Pharmaceuticals announced a collaboration to commercialize Olopatadine hydrochloride and mometasone furoate nasal spray used in the treatment of seasonal allergic rhinitis.
Side effects associated with mometasone is expected to hinder mometasone market growth. Pricing competition among market players’ challenges mometasone market growth.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32010
Mometasone Market: Segmentation
| Based on the dosage form |
|
| Based on the prescription type |
|
| Based on the indication |
|
| Based on the route of administration |
|
| Based on the distribution channel |
|
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32010
Based on indication, inflammatory skin disorders contributes higher to mometasone market. Retail pharmacies is the largest distribution channel in the mometasone market followed by hospital pharmacies. Online pharmacies will observe a significant rise in demand with an increased rate of adoption in the mometasone market during the forecast period.
Asia-pacific is lucrative with a high growth rate in the mometasone market during the forecast period with an increased inflammatory skin disorders patient population in the region. Asia-Pacific region is lucrative for mometasone market growth with an increasing number of domestic manufacturers.
The Middle East and Africa are expected to observe the least growth in mometasone market due to less healthcare expenditure in the region. Poor economic conditions in the Middle East and Africa make them untapped regions with fewer growth opportunities of mometasone market.
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com